2m 2m 2m 2m 2m 2m 2m
RXSIGHT (RXST)
NASDAQ
$4.69-$0.07 (-1.37%)
Price as of Oct 02, 2026 4:20 PM EDT- $197.6MMarket Cap
- -44.51%1-Year Change
- Medical DevicesIndustry
RXSIGHT (RXST)
$4.69-$0.07 (-1.37%)
RXST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.75 | ||
Change | -$0.15 (-3.06%) | ||
Open | $4.88 | ||
High | $4.89 | ||
Low | $4.74 | ||
Previous Close | $4.90 | ||
Volume | 508,921 | ||
30-Day Average Volume | 801,941 | ||
1-Week Change | 0.42% | ||
1-Month Change | -32.05% | ||
1-Year Change | -44.51% | ||
3-Year Change | -82.97% | ||
5-Year Change | -63.57% | ||
Fundamentals | |||
Shares Outstanding | 41.6M | ||
Total Assets | $352.7M | ||
Market Cap | $197.6M | ||
Enterprise Value | $184.2M | ||
Period: QTR TTM FY | |||
Revenue | $27.2M | ||
Net Income | -$12.1M | ||
Free Cash Flow | -$11.5M | ||
EBIT | -$12.0M | ||
EBITDA | -$11.0M | ||
Net Working Capital | $247.0M | ||
EPS | -$0.29 | ||
Enterprise Value/EBITDA | -17 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 1 | ||
P/E | -16 | ||
PEG | -1 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 9 : 1 | ||
Last Split Date | 09/21/2006 | ||
Earnings & Revenue